Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)

NCT02037984 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

341

Enrollment

INDUSTRY

Sponsor class

Conditions

Streptococcus Pneumoniae Infection
Pneumococcal Infections

Interventions

BIOLOGICAL: Prevnar 13®
BIOLOGICAL: V114 1x:1x:1x
BIOLOGICAL: V114 2x:2x:2x
BIOLOGICAL: V114 2x:1x:2x
BIOLOGICAL: V114 1x:1x:2x
BIOLOGICAL: V114 0.5x:0.5x:2x

Sponsor

Merck Sharp & Dohme LLC